Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date30 Nov 2002 |
100 Clinical Results associated with Jilin Zhenghe Pharmaceutical Group Co., Ltd.
0 Patents (Medical) associated with Jilin Zhenghe Pharmaceutical Group Co., Ltd.
100 Deals associated with Jilin Zhenghe Pharmaceutical Group Co., Ltd.
100 Translational Medicine associated with Jilin Zhenghe Pharmaceutical Group Co., Ltd.